Komori
Governance4597Solasia Pharma K.K.Pharmaceuticals

Independent Officer Notification Form

The company filed a notification of independent officers in connection with the submission of an agenda item for the election of outside directors at the annual general meeting of shareholders scheduled for 25 March 2026. It has reported a total of 6 people as independent officers, comprising 3 outside directors and 3 outside corporate auditors.

Worth reading
33Immaterial
Scored from 1 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
6
Independent officers (3 outside directors and 3 outside Audit & Supervisory Board Members)
Wording
Definitive
How definitive the wording is.

Governance structure

Number of independent officers6Number

This is the number of people reported to the exchange as independent officers. Whether someone is an outside officer and whether they qualify as independent are separate determinations.

Changes this time

2026年3月25日開催予定の第18回定時株主総会に社外取締役の選任議案を付議するため、独立役員届出書を提出。社外取締役3名、社外監査役3名を独立役員として届け出ている。

Governance structure
ItemDetails
Number of independent officers6
Changes this time2026年3月25日開催予定の第18回定時株主総会に社外取締役の選任議案を付議するため、独立役員届出書を提出。社外取締役3名、社外監査役3名を独立役員として届け出ている。
Items this document does not state (6)
Corporate Governance StructureNumber of directorsCommitteePolicy on cross-shareholdingsTakeover defensesControlling shareholder

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

2026年3月25日に開催予定の第18回定時株主総会に社外取締役の選任議案を付議するため。

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Independent Officer Notification Form | Solasia Pharma K.K. (4597) timely disclosure | Komori